International Biotechnology Trust’s Globus Medical GMED Stock Holding History

International Biotechnology Trust’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-24,200	Closed	-$1.43M	–	57
2019 Q4	$1.43M	Hold	24,200	–	–	0.51%	41
2019 Q3	$1.24M	Hold	24,200	–	–	0.57%	35
2019 Q2	$1.02M	Hold	24,200	–	–	0.38%	50
2019 Q1	$1.2M	Hold	24,200	–	–	0.44%	52
2018 Q4	$822K	Sell	24,200 -4,800	-17%	-$239K	0.51%	35
2018 Q3	$1.26M	Hold	29,000	–	–	0.6%	39
2018 Q2	$1.46M	Hold	29,000	–	–	0.56%	40
2018 Q1	$1.45M	Buy	+29,000	New	+$1.36M	0.56%	41

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

International Biotechnology Trust's GMED Position: Q1 2020 in Review

International Biotechnology Trust sold out of Globus Medical (GMED) in Q1 2020, closing a stake of 24,200 shares — an estimated $1.43M sold.

International Biotechnology Trust first reported a position in GMED in Q1 2018 and held it in 8 quarters. The position peaked at $1.46M in Q2 2018. 273 funds tracked by Wall St. Rank hold GMED as of Q1 2020.

International Biotechnology Trust reported no remaining Globus Medical position as of Q1 2020 after selling out during the quarter.
International Biotechnology Trust sold 24,200 Globus Medical shares in Q1 2020, an estimated $1.43M.
International Biotechnology Trust first reported a position in Globus Medical in Q1 2018 and held it in 8 quarters.
International Biotechnology Trust's Globus Medical position peaked at $1.46M in Q2 2018.
273 funds tracked by Wall St. Rank held Globus Medical as of Q1 2020.

Based on International Biotechnology Trust's 13F filing for Q1 2020, filed 18 May 2020.